Antimicrobial Resistance (AMR) Genotyping Panels Market Growth Forecast Through 2030: Market Size And Trends In 2026
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Antimicrobial Resistance (AMR) Genotyping Panels Market Poised To Hit $2.81 Billion By 2030 With A 14.1% CAGR
The antimicrobial resistance (AMR) genotyping panels market has experienced rapid growth in recent years. It is projected to expand from $1.45 billion in 2025 to $1.66 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.4%. This growth in the historic period is attributable to the increasing prevalence of antimicrobial resistance, a rise in hospital-acquired infections, the expansion of molecular diagnostic capabilities, greater awareness of resistance monitoring, and the availability of advanced genotyping technologies.
The antimicrobial resistance (amr) genotyping panels market size is anticipated to experience substantial growth in the coming years. This market is projected to reach $2.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. Key factors driving this expansion during the forecast period include increasing investments in infectious disease diagnostics, rising demand for rapid point-of-care testing, expansion of genomic epidemiology programs, growing integration of amr data analytics, and an increasing regulatory focus on resistance surveillance. Significant trends anticipated in the forecast period encompass increasing adoption of multiplex resistance detection panels, rising use of rapid molecular diagnostics, growing integration of genomic surveillance tools, expansion of hospital-based amr testing, and an enhanced focus on early resistance identification.
Get A Free Sample Report With In-Depth Market Insights:
Antimicrobial Resistance (AMR) Genotyping Panels Market Demand Drivers: What’s Powering Industry Growth?
The increasing incidence of infections resistant to antimicrobials is anticipated to drive the expansion of the antimicrobial resistance (AMR) genotyping panels market in the future. These infections are defined as illnesses resulting from microorganisms like bacteria, viruses, fungi, or parasites that have developed resistance to conventional antimicrobial medications, rendering treatment more challenging. Key contributors to the rise in antimicrobial resistance involve the excessive and inappropriate use of antibiotics. Such practices have hastened the appearance of resistant disease-causing agents, thereby boosting the need for AMR genotyping panels capable of quickly detecting resistance genes and directing specific antimicrobial therapies. For example, data from the Centers for Disease Control and Prevention (CDC) indicates that over 2.8 million antimicrobial-resistant infections happen annually within the US. Consequently, the growing occurrence of antimicrobial-resistant infections is fueling the market growth for AMR genotyping panels.
Antimicrobial Resistance (AMR) Genotyping Panels Market Segmentation And Category Overview
The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –
1) By Product Type: Custom Panels, Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies
3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users
Subsegments:
1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels
2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels
Antimicrobial Resistance (AMR) Genotyping Panels Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies operating in the antimicrobial resistance (AMR) genotyping panels market are concentrating on developing innovative products, such as multiplex PCR-based research assays, to facilitate the simultaneous detection of multiple pathogens and antibiotic resistance genes in a single test, thereby enhancing research efficiency and supporting faster identification of emerging resistance patterns. Multiplex PCR-based research assays are molecular tests that amplify and detect multiple genetic targets at once to identify pathogens and antibiotic resistance genes in a single reaction. For instance, in September 2025, Molecular Designs, a US-based molecular diagnostics and research-assay company, introduced the Urogenital Microbiota with ABX 53 Simplicity Panel, a multiplex PCR-based research assay designed to detect urinary pathogens and antibiotic resistance genes in a single test. This panel enables the simultaneous detection of 28 urogenital and urinary microbial targets (20 bacterial, 7 fungal, and 1 protozoan) alongside 25 antibiotic-resistance gene markers, offering same-day turnaround and availability in both 96-well and 384-well plate formats, with breakaway panels included in the 96-well version to reduce waste.
Antimicrobial Resistance (AMR) Genotyping Panels Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
View The Full Antimicrobial Resistance (AMR) Genotyping Panels Market Report:
Antimicrobial Resistance (AMR) Genotyping Panels Market Regional Analysis And Top Geography
North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
